Triple

T16115543
Position Surface form Disambiguated ID Type / Status
Subject Association for Molecular Pathology v. Myriad Genetics, Inc. E390992 entity
Predicate fullName P16 FINISHED
Object Association for Molecular Pathology v. Myriad Genetics, Inc. E390992 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Association for Molecular Pathology v. Myriad Genetics, Inc. | Statement: [Association for Molecular Pathology v. Myriad Genetics, Inc., fullName, Association for Molecular Pathology v. Myriad Genetics, Inc.]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Association for Molecular Pathology v. Myriad Genetics, Inc.
Context triple: [Association for Molecular Pathology v. Myriad Genetics, Inc., fullName, Association for Molecular Pathology v. Myriad Genetics, Inc.]
  • A. Association for Molecular Pathology v. Myriad Genetics, Inc. chosen
    Association for Molecular Pathology v. Myriad Genetics, Inc. is a landmark 2013 U.S. Supreme Court case that held naturally occurring human genes cannot be patented, reshaping the legal landscape for biotechnology and genetic testing.
  • B. Myriad Genetics
    Myriad Genetics is a biotechnology company best known for developing and commercializing genetic tests, particularly for assessing inherited cancer risk.
  • C. In re Chakrabarty
    In re Chakrabarty is a landmark 1980 U.S. Supreme Court case that held genetically engineered living organisms can be patented, significantly shaping modern biotechnology patent law.
  • D. NFIB v. Sebelius
    NFIB v. Sebelius is the landmark 2012 U.S. Supreme Court case that largely upheld the Affordable Care Act, notably ruling that its individual mandate could be sustained under Congress’s taxing power.
  • E. Myriad Gardens Foundation
    The Myriad Gardens Foundation is a nonprofit organization that manages and supports the Myriad Botanical Gardens in Oklahoma City through stewardship, programming, and fundraising.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d87f1a8dd881909f1de6ef78849874 completed April 10, 2026, 4:39 a.m.
NER Named-entity recognition batch_69e2016a9dd48190bca3f58778ed865f completed April 17, 2026, 9:46 a.m.
NED1 Entity disambiguation (via context triple) batch_69ffebab779c8190b466c26f4024aa31 completed May 10, 2026, 2:21 a.m.
Created at: April 10, 2026, 5 a.m.